
### [MONDO:0019565](http://purl.obolibrary.org/obo/MONDO_0019565)
**Label:** von willebrand disease

**Subclasses:** [MONDO:0015631](http://purl.obolibrary.org/obo/MONDO_0015631) (von willebrand disease type 2N), [MONDO:0015630](http://purl.obolibrary.org/obo/MONDO_0015630) (von willebrand disease type 2M), [MONDO:0015628](http://purl.obolibrary.org/obo/MONDO_0015628) (von willebrand disease type 2A), [MONDO:0015629](http://purl.obolibrary.org/obo/MONDO_0015629) (von willebrand disease type 2B), [MONDO:0010756](http://purl.obolibrary.org/obo/MONDO_0010756) (von willebrand disease, X-linked form), [MONDO:0008668](http://purl.obolibrary.org/obo/MONDO_0008668) (von willebrand's disease 1), [MONDO:0010191](http://purl.obolibrary.org/obo/MONDO_0010191) (von willebrand's disease 3), [MONDO:0013304](http://purl.obolibrary.org/obo/MONDO_0013304) (von willebrand's disease 2), 

**Corr. equiv. classes:** [Orphanet:166090](http://www.orpha.net/ORDO/Orphanet_166090), [OMIM:314560](http://purl.obolibrary.org/obo/OMIM_314560), [Orphanet:166084](http://www.orpha.net/ORDO/Orphanet_166084), [OMIM:613554](http://purl.obolibrary.org/obo/OMIM_613554), [Orphanet:166093](http://www.orpha.net/ORDO/Orphanet_166093), [OMIM:277480](http://purl.obolibrary.org/obo/OMIM_277480), [Orphanet:166081](http://www.orpha.net/ORDO/Orphanet_166081), [Orphanet:166087](http://www.orpha.net/ORDO/Orphanet_166087), [OMIM:193400](http://purl.obolibrary.org/obo/OMIM_193400), [Orphanet:166096](http://www.orpha.net/ORDO/Orphanet_166096), [Orphanet:166078](http://www.orpha.net/ORDO/Orphanet_166078), 

**Class expressions from DL-Learner:**

- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) and [HP:0000978](http://purl.obolibrary.org/obo/HP_0000978) (Bruising susceptibility) 33.50%
- [HP:0000132](http://purl.obolibrary.org/obo/HP_0000132) (Menorrhagia) 29.45%
- [HP:0003010](http://purl.obolibrary.org/obo/HP_0003010) (Prolonged bleeding time) 27.16%
- [HP:0001892](http://purl.obolibrary.org/obo/HP_0001892) (Abnormal bleeding) 23.01%
- [HP:0000421](http://purl.obolibrary.org/obo/HP_0000421) (Epistaxis) 22.92%
- [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 20.80%
- [HP:0001933](http://purl.obolibrary.org/obo/HP_0001933) (Subcutaneous hemorrhage) 20.15%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 19.20%
- Thing 19.20%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 19.20%
- [HP:0000818](http://purl.obolibrary.org/obo/HP_0000818) (Abnormality of the endocrine system) 16.04%
- [HP:0000119](http://purl.obolibrary.org/obo/HP_0000119) (Abnormality of the genitourinary system) 15.30%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 15.28%
- [HP:0001574](http://purl.obolibrary.org/obo/HP_0001574) (Abnormality of the integument) 15.12%
- [HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck) 14.93%


